Dennis Gillings, chairman and chief executive officer of Quintiles Transnational Corp

We work in the cardiovascular arena and we concentrate on some of the therapeutic areas through phase 2 and phase 3 and also the regulatory agency through which the drug is going to be ultimately approved. After Phase 1 it takes about 3/4 yrs before a product is applied for marketing permission in a regulatory agency. All the clinical phases would now be done in India. We are now on target and are doing reasonably well. India is a good regulatory regime in terms of encouraging clinical research. It doesn't encourage innovation to the same extent as Europe and N.America. It does encourage Indian companies for Indian products

Category:

Autos & Vehicles

Tags:

• hybiz.tv Dennis Gillings